Free Trial
OTCMKTS:SARTF

Sartorius Aktiengesellschaft (SARTF) Stock Price, News & Analysis

Sartorius Aktiengesellschaft logo
$174.54 -3.71 (-2.08%)
As of 04/2/2025 02:34 PM Eastern

About Sartorius Aktiengesellschaft Stock (OTCMKTS:SARTF)

Key Stats

Today's Range
$174.54
$174.54
50-Day Range
$174.54
$243.35
52-Week Range
$174.54
$252.54
Volume
30 shs
Average Volume
97 shs
Market Capitalization
$5.97 billion
P/E Ratio
132.23
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Strong Buy

Company Overview

Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products. In addition, the company offers water purification systems; surface plasmon resonance; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, equipment manufacturer cells, weights and weight sets, paint mixing solutions, and weighing accessories; and process filtration. Further, the company provides bioprocess consulting and engineering, biologics testing, media and process, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, pharmaceutical quality control, cell and gene therapy, and applied industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Göttingen, Germany.

Remove Ads
Receive SARTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sartorius Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

SARTF Stock News Headlines

DOGE tax surprise
Elon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax authorities have bought a powerful new AI supercomputer, worth millions of dollars. It's the most advanced technology offered by AI giant Nvidia. And it's almost certainly going to be used to advance Elon Musk's real agenda with DOGE... the massive, rapid roll out of AI across the entire federal government.
Sartorius 9-month Underlying Net Profit Declines; Confirms 2024 Guidance
Sartorius vz earnings: here's what Wall Street expects
See More Headlines

SARTF Stock Analysis - Frequently Asked Questions

Sartorius Aktiengesellschaft's stock was trading at $184.00 on January 1st, 2025. Since then, SARTF shares have decreased by 5.1% and is now trading at $174.54.
View the best growth stocks for 2025 here
.

Sartorius Aktiengesellschaft (OTCMKTS:SARTF) announced its quarterly earnings data on Monday, February, 17th. The company reported $1.11 earnings per share for the quarter. The business had revenue of $967.37 million for the quarter. Sartorius Aktiengesellschaft had a net margin of 2.48% and a trailing twelve-month return on equity of 7.33%.

The following companies are subsidiaries of Sartorius Aktiengesellschaft: Novasep’s chromatography division, ALS Automated Lab Solutions GmbH, Xell AG, CellGenix Inc., WaterSep BioSeparations LLC, BIA Separations, Biological Industries, and more.

Shares of SARTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
2/17/2025
Today
4/03/2025
Next Earnings (Estimated)
4/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Dental equipment & supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:SARTF
Previous Symbol
NASDAQ:SARTF
CIK
N/A
Employees
14,614
Year Founded
1870

Profitability

Trailing P/E Ratio
132.23
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$221.98 million
Pretax Margin
5.94%

Debt

Sales & Book Value

Annual Sales
$3.66 billion
Cash Flow
$26.09 per share
Price / Cash Flow
6.69
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$5.97 billion
Optionable
Not Optionable
Beta
1.11

Social Links

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (OTCMKTS:SARTF) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners